cp 46665 has been researched along with lysophosphatidylcholines in 2 studies
| Studies (cp 46665) | Trials (cp 46665) | Recent Studies (post-2010) (cp 46665) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, S; Olson, AC; Vogler, WR | 1 |
| Berdel, WE; Eibl, H; Fink, U; Rastetter, J; Reichert, A; Schick, HD; Unger, C; Von Hoff, DD | 1 |
2 other study(ies) available for cp 46665 and lysophosphatidylcholines
| Article | Year |
|---|---|
Elimination of leukemic cells by the combined use of ether lipids in vitro.
Topics: Blood; Cell Line; Cell Survival; Clone Cells; Drug Synergism; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Lysophosphatidylcholines; Phospholipid Ethers; Piperidines; Stem Cells; Temperature | 1987 |
Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
Topics: Antineoplastic Agents; Cell Survival; Female; Humans; Lysophosphatidylcholines; Neoplasms; Phospholipid Ethers; Piperidines; Structure-Activity Relationship | 1986 |